THROMBOSIS RESEARCH INSTITUTE
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://tri-london.ac.uk
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Thrombosis Research Institute
- Target Recruit Count
- 219
- Registration Number
- NCT04492254
- Locations
- 🇦🇺
Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital, Melbourne, Australia
🇧🇪Dr Frank Cools, National Co-ordinating Investigator, AZ Klina, Brasschaat, Belgium
🇿🇦Prof. Barry Jacobson, National Coordinating Investigator, University of the Witwatersrand, Johannesburg, South Africa
Rivaroxaban Evaluation in Real Life Settings
- Conditions
- StrokeAtrial Fibrillation
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Thrombosis Research Institute
- Target Recruit Count
- 5278
- Registration Number
- NCT02444221
- Locations
- 🇫🇷
Prof. Jean-Yues LeHeuzey, National Coordinating Investigator, Hopital Europeen Georges Pompidou, Paris, France
🇬🇧Thrombosis Research Institute, London, United Kingdom
Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
- Conditions
- Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism
- First Posted Date
- 2014-06-04
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Thrombosis Research Institute
- Target Recruit Count
- 10679
- Registration Number
- NCT02155491
- Locations
- 🇺🇸
Dr Terence Hart, Muscle Shoals, Alabama, United States
Global Anticoagulant Registry in the Field
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2010-03-19
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Thrombosis Research Institute
- Target Recruit Count
- 57250
- Registration Number
- NCT01090362
- Locations
- 🇺🇸
Prof. Samuel Goldhaber, Boston, Massachusetts, United States
🇦🇷Dr Hector Luciardi, National Co-ordinating Investigator, National University of Tucuman, Tucumán, Argentina
🇦🇺Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital, Melbourne, Australia
Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT
- Conditions
- Gastroesophageal CancerGastric Cancer
- Interventions
- Drug: Standard Chemotherapy
- First Posted Date
- 2008-07-18
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Thrombosis Research Institute
- Target Recruit Count
- 740
- Registration Number
- NCT00718354
- Locations
- 🇮🇳
Mahatma Gandhi Cancer Hospital & Research Institute ,1/7 M.V.P. Colony, - ,, ., Vishakhapattanam, Andhra Pradesh, India
🇮🇳Mahavir Cancer Sansthan,Phulwari Sharif, Patna, Bihar, India
🇮🇳Gujarat Cancer Research Institute, Civil Hospital Campus,Asarwa, ,, Ahmedabad, Gujarat,, India